Cargando…

Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer

Innovative therapeutic agents have significantly improved outcome with an acceptable safety profile in a substantial proportion of non-small cell lung cancer (NSCLC) patients, who depend on oncogenic molecular alterations for their malignant phenotype. Despite the survival improvement achieved with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lazzari, Chiara, Bulotta, Alessandra, Ducceschi, Monika, Viganò, Maria Grazia, Brioschi, Elena, Corti, Francesca, Gianni, Luca, Gregorc, Vanesa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253463/ https://www.ncbi.nlm.nih.gov/pubmed/28168189 http://dx.doi.org/10.3389/fmed.2017.00004

Ejemplares similares

PD-1 Inhibitors-Related Neurological Toxicities in Patients with Non-Small-Cell Lung Cancer: A Literature Review
por: Mirabile, Aurora, et al.
Publicado: (2019)

Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?
por: Lazzari, Chiara, et al.
Publicado: (2018)

Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence
por: Mirabile, Aurora, et al.
Publicado: (2020)

History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature
por: Lazzari, Chiara, et al.
Publicado: (2021)

Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung Cancer
por: Gregorc, Vanesa, et al.
Publicado: (2021)

Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib
por: Lazzari, Chiara, et al.
Publicado: (2022)

Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies
por: Petrelli, Fausto, et al.
Publicado: (2018)

Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies
por: Lazzari, Chiara, et al.
Publicado: (2023)

NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer
por: Gregorc, Vanesa, et al.
Publicado: (2018)

Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies
por: Giovannini, Monica, et al.
Publicado: (2009)

Next Generation Sequencing in Non-Small Cell Lung Cancer: Pitfalls and Opportunities
por: Lazzari, Chiara, et al.
Publicado: (2020)

Mechanisms of resistance to osimertinib
por: Lazzari, Chiara, et al.
Publicado: (2020)

Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH?
por: Pecciarini, Lorenza, et al.
Publicado: (2023)

Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma
por: Pontara, Andrea, et al.
Publicado: (2020)

Spontaneous Regression of Primary Melanoma and Multiple Melanocytic Nevi in a Patient With Metastatic Melanoma
por: Paolino, Giovanni, et al.
Publicado: (2020)

KRAS in NSCLC: State of the Art and Future Perspectives
por: Cascetta, Priscilla, et al.
Publicado: (2022)

Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example
por: Corti, Angelo, et al.
Publicado: (2013)

Evolution of Myocardial Infarction and its Biomarkers: A Historical Perspective
por: Hajar, Rachel
Publicado: (2016)

Emergency Department Visits among Cancer Patients during SARS-CoV-2 Pandemic
por: Valsecchi, Davide, et al.
Publicado: (2023)

Historical eye on IPF: a cohort study redefining the mortality scenario
por: Tomassetti, Sara, et al.
Publicado: (2023)

Evolution of Surgical Repair of Patent Ductus Arteriosus - A Historical Timeline
por: Murshid, Mohsin Yahya, et al.
Publicado: (2021)

Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysis
por: Garassino, Marina Chiara, et al.
Publicado: (2018)

Immunotherapeutic Advances for NSCLC
por: Massafra, Marco, et al.
Publicado: (2021)

Focus on Alectinib and Competitor Compounds for Second-Line Therapy in ALK-Rearranged NSCLC
por: Tran, Phu N., et al.
Publicado: (2016)

Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives
por: Lazzari, Chiara, et al.
Publicado: (2023)

Romiplostim and Eltrombopag in Immune Thrombocytopenia as a Second-Line Treatment
por: Bidika, Erjola, et al.
Publicado: (2020)

Second-Line Treatment of NSCLC—The Pan-ErbB Inhibitor Afatinib in Times of Shifting Paradigms
por: Köhler, Jens
Publicado: (2017)

Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib
por: Zugazagoitia, Jon, et al.
Publicado: (2017)

Malaria in Europe: A Historical Perspective
por: Boualam, Mahmoud A., et al.
Publicado: (2021)

Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma
por: Carretta, Angelo, et al.
Publicado: (2020)

Historical Evolution and Present Status of Family Medicine in Sri Lanka
por: Ramanayake, R. P. J. C.
Publicado: (2013)

Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib
por: Corrales, Luis, et al.
Publicado: (2017)

ALADDIN study: does assisted hatching of vitrified/warmed blastocysts improve live birth rate? Protocol for a multicentric randomised controlled trial
por: Alteri, Alessandra, et al.
Publicado: (2020)

Particular hyperpigmentation of the soft palate
por: Casu, Cinzia, et al.
Publicado: (2018)

Particular shape of the tongue and benign migratory glossitis
por: Casu, Cinzia, et al.
Publicado: (2018)

Oral lichen planus and HPV lesions
por: Casu, Cinzia, et al.
Publicado: (2018)

Economic Evaluation of Rituximab + Recombinant Human Thrombopoietin vs. Rituximab for the Treatment of Second-Line Idiopathic Thrombocytopenic Purpura in China
por: Rui, Mingjun, et al.
Publicado: (2021)

FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort
por: Maugeri-Saccà, Marcello, et al.
Publicado: (2013)

Hemorrhagic Colitis Induced by Second-line Helicobacter pylori Eradication
por: Hamada, Yasuhiko, et al.
Publicado: (2019)

Historical perspective of Indian neurology
por: Mishra, Shrikant, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_r0i8arob07pef8r9hqikadeffr